InvestSMART

Regis Healthcare Limited (ASX: REG) - Announcements

Current share price for REG : $6.170 0.05 (0.82%)+

ASX company news and announcements for Regis Healthcare Limited (REG) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Regis Healthcare Limited (REG) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Regis Healthcare Limited (REG), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Regis Healthcare Limited (REG)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,866 Regis Healthcare 4D and Financial Report 1H FY19 22 Feb 2019 8:26AM $3.380 $6.170 risen by 82.54%
$1,866 Regis - Half Year FY19 Reporting Date 6 Feb 2019 10:37AM $2.980 $6.170 risen by 107.05%
$1,866 Regis Healthcare - UBS Conference 13 Nov 2018 9:45AM $2.640 $6.170 risen by 133.71%
$1,866 Change of Director's Interest Notice 1 Nov 2018 2:31PM $2.430 $6.170 risen by 153.91%
$1,866 Regis Healthcare - Results of Annual General Meeting 25 Oct 2018 1:20PM $2.470 $6.170 risen by 149.80%
$1,866 Regis Healthcare - Chairman and MD addresses to AGM 25 Oct 2018 9:40AM $2.520 $6.170 risen by 144.84%
$1,866 Ceasing to be a substantial holder from CBA 28 Sep 2018 4:48PM $2.890 $6.170 risen by 113.49%
$1,866 Appendix 4G And Corporate Governance Statement 20 Sep 2018 2:09PM $2.950 $6.170 risen by 109.15%
$1,866 Annual Report to shareholders 20 Sep 2018 2:09PM $2.950 $6.170 risen by 109.15%
$1,866 Notice of Annual General Meeting/Proxy Form 20 Sep 2018 2:04PM $2.950 $6.170 risen by 109.15%
$1,866 Becoming a substantial holder from CBA 20 Sep 2018 1:25PM $2.955 $6.170 risen by 108.80%
$1,866 Regis Appendis 3B 13 Sep 2018 5:48PM $3.600 $6.170 risen by 71.39%
$1,866 Dividend/Distribution - REG 31 Aug 2018 9:49AM $3.550 $6.170 risen by 73.80%
$1,866 Regis Healthcare Investor Presentation FY2018 Results 31 Aug 2018 9:08AM $3.550 $6.170 risen by 73.80%
$1,866 Regis Healthcare Results Announcement FY2018 31 Aug 2018 9:02AM $3.550 $6.170 risen by 73.80%
$1,866 Regis Healthcare Appendix 4E and Financial Report FY2018 31 Aug 2018 8:59AM $3.550 $6.170 risen by 73.80%
$1,866 AGM Date 13 Aug 2018 10:50AM $3.380 $6.170 risen by 82.54%
$1,866 Notification of Annual Results FY18 Reporting Date 23 Jul 2018 12:19PM $3.485 $6.170 risen by 77.04%
$1,866 Final Director's Interest Notice 4 Jul 2018 9:39AM $3.360 $6.170 risen by 83.63%
$1,866 Presentation for the Macquarie Securities Conference 2018 2 May 2018 9:46AM $3.850 $6.170 risen by 60.26%
$1,866 Board Succession 19 Apr 2018 9:47AM $3.660 $6.170 risen by 68.58%
$1,866 Federal Court Judgement Update 8 Mar 2018 11:00AM $4.000 $6.170 risen by 54.25%
$1,866 Regis Healthcare Federal Court Judgment 2 Mar 2018 2:58PM $4.170 $6.170 risen by 47.96%
$1,866 Initial Director's Interest Notice 2 Mar 2018 9:50AM $4.140 $6.170 risen by 49.03%
$1,866 Initial Director's Interest Notice 2 Mar 2018 9:49AM $4.140 $6.170 risen by 49.03%

276 - 300 of 389 results

Page 12 of 16

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.